DCP Stock Overview
Engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Dis-Chem Pharmacies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R36.82 |
| 52 Week High | R37.40 |
| 52 Week Low | R22.30 |
| Beta | 0.18 |
| 11 Month Change | 3.75% |
| 3 Month Change | 10.24% |
| 1 Year Change | 46.11% |
| 33 Year Change | 21.52% |
| 5 Year Change | 76.26% |
| Change since IPO | 71.42% |
Recent News & Updates
Recent updates
These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well
Aug 21
Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price
Jun 06Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around
Apr 17Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly
Feb 26Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively
Dec 30If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity
Sep 07Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly
Aug 16Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends
Jul 31Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
May 09There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Mar 29Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
Jan 14Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture
Nov 04Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate
Oct 04We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Sep 01Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Jul 04A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)
Jun 21Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet
Jun 08The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts
May 25Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?
Feb 23Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings
Feb 08I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Dec 13Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality
Nov 09Shareholder Returns
| DCP | ZA Consumer Retailing | ZA Market | |
|---|---|---|---|
| 7D | 2.4% | 2.0% | 4.2% |
| 1Y | 46.1% | 18.0% | 14.0% |
Return vs Industry: DCP exceeded the ZA Consumer Retailing industry which returned 18% over the past year.
Return vs Market: DCP exceeded the ZA Market which returned 14% over the past year.
Price Volatility
| DCP volatility | |
|---|---|
| DCP Average Weekly Movement | 3.9% |
| Consumer Retailing Industry Average Movement | 4.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in ZA Market | 10.7% |
| 10% least volatile stocks in ZA Market | 3.4% |
Stable Share Price: DCP has not had significant price volatility in the past 3 months.
Volatility Over Time: DCP's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | n/a | Rui Morais | dischemgroup.com |
Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments, Retail and Wholesale. It owns and operates a chain of retail stores that offers a range of products, including dispensary, personal care and beauty, healthcare and nutrition, baby care, and other products.
Dis-Chem Pharmacies Limited Fundamentals Summary
| DCP fundamental statistics | |
|---|---|
| Market cap | R31.57b |
| Earnings (TTM) | R984.48m |
| Revenue (TTM) | R36.28b |
32.1x
P/E Ratio0.9x
P/S RatioIs DCP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DCP income statement (TTM) | |
|---|---|
| Revenue | R36.28b |
| Cost of Revenue | R28.07b |
| Gross Profit | R8.22b |
| Other Expenses | R7.23b |
| Earnings | R984.48m |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
Nov 01, 2024
| Earnings per share (EPS) | 1.15 |
| Gross Margin | 22.65% |
| Net Profit Margin | 2.71% |
| Debt/Equity Ratio | 58.6% |
How did DCP perform over the long term?
See historical performance and comparison